Rubra Medicaments has informed that the meeting of the Board of Directors of the Company is scheduled on 24/05/2019, to consider and approve adoption of Standalone Audited Financial Result of the Company for the Quarter and Year ended March 31, 2019.
The above information is a part of company's filings submitted to BSE.